
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $520.8M | $607.2M | $651.5M | $627.6M | $572.5M | |
Revenue Growth (YoY) | -18.12% | 16.59% | 7.29% | -3.67% | -8.79% | |
Cost of Revenues | $301.4M | $347.1M | $375M | $360.6M | $315.6M | |
Gross Profit | $219.4M | $260.1M | $276.5M | $267M | $256.8M | |
Gross Profit Margin | 42.13% | 42.83% | 42.44% | 42.55% | 44.86% | |
R&D Expenses | $84M | $88.3M | $92.9M | $94.4M | $99.1M | |
Selling, General & Admin | $205.2M | $250.9M | $240.8M | $260.2M | $243.3M | |
Other Inc / (Exp) | -$386.2M | $14.4M | $39.1M | -- | -- | |
Operating Expenses | $289.2M | $339.2M | $333.6M | $354.6M | $342.5M | |
Operating Income | -$69.8M | -$79.2M | -$57.2M | -$87.6M | -$85.7M | |
Net Interest Expenses | $575K | $2.1M | -- | -- | -- | |
EBT. Incl. Unusual Items | -$456.6M | -$66.8M | -$17.8M | -$84.6M | -$84M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$16.4M | -$3.9M | $5.5M | $5.8M | $3M | |
Net Income to Company | -$444.1M | -$62M | -$29M | -$123.1M | -$120.3M | |
Minority Interest in Earnings | $395K | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$443.7M | -$62M | -$29M | -$123.1M | -$120.3M | |
Basic EPS (Cont. Ops) | -$8.08 | -$0.98 | -$0.44 | -$1.79 | -$1.70 | |
Diluted EPS (Cont. Ops) | -$8.08 | -$0.98 | -$0.44 | -$1.79 | -$1.70 | |
Weighted Average Basic Share | $54.9M | $63.5M | $66.5M | $68.7M | $70.9M | |
Weighted Average Diluted Share | $54.9M | $63.5M | $66.5M | $68.7M | $70.9M | |
EBITDA | -$20.3M | -$23.1M | $2.6M | -$38.6M | -$40.3M | |
EBIT | -$69.8M | -$79.2M | -$57.2M | -$87.6M | -$85.7M | |
Revenue (Reported) | $520.8M | $607.2M | $651.5M | $627.6M | $572.5M | |
Operating Income (Reported) | -$69.8M | -$79.2M | -$57.2M | -$87.6M | -$85.7M | |
Operating Income (Adjusted) | -$69.8M | -$79.2M | -$57.2M | -$87.6M | -$85.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $134.2M | $163.4M | $149.4M | $144.1M | $136M | |
Revenue Growth (YoY) | 0.97% | 21.79% | -8.6% | -3.57% | -5.56% | |
Cost of Revenues | $78.6M | $93.8M | $84M | $80.2M | $75.8M | |
Gross Profit | $55.6M | $69.7M | $65.4M | $63.9M | $60.2M | |
Gross Profit Margin | 41.42% | 42.63% | 43.78% | 44.36% | 44.28% | |
R&D Expenses | $20.6M | $24M | $21.5M | $24M | $18.8M | |
Selling, General & Admin | $53.3M | $65.3M | $60.7M | $64.4M | $53.9M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $73.9M | $89.3M | $82.2M | $88.4M | $72.6M | |
Operating Income | -$18.4M | -$19.6M | -$16.8M | -$24.5M | -$12.4M | |
Net Interest Expenses | $377K | $1.4M | -- | -- | -- | |
EBT. Incl. Unusual Items | -$18.7M | -$20.9M | -$16M | -$23.2M | -$10.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$942K | -$73K | $3.8M | $716K | $455K | |
Net Income to Company | -$18.9M | -$20.9M | -$22.2M | -$26M | -$13.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$18.9M | -$20.9M | -$22.2M | -$26M | -$13.1M | |
Basic EPS (Cont. Ops) | -$0.32 | -$0.32 | -$0.33 | -$0.37 | -$0.18 | |
Diluted EPS (Cont. Ops) | -$0.32 | -$0.32 | -$0.33 | -$0.37 | -$0.18 | |
Weighted Average Basic Share | $58.6M | $65.7M | $67.6M | $70M | $72M | |
Weighted Average Diluted Share | $58.6M | $65.7M | $67.6M | $70M | $72M | |
EBITDA | -$4.6M | -$4.3M | -$5.1M | -$12.2M | -$1.6M | |
EBIT | -$18.4M | -$19.6M | -$16.8M | -$24.5M | -$12.4M | |
Revenue (Reported) | $134.2M | $163.4M | $149.4M | $144.1M | $136M | |
Operating Income (Reported) | -$18.4M | -$19.6M | -$16.8M | -$24.5M | -$12.4M | |
Operating Income (Adjusted) | -$18.4M | -$19.6M | -$16.8M | -$24.5M | -$12.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $522.1M | $636.5M | $637.4M | $622.3M | $564.5M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $307M | $362.3M | $365.2M | $356.7M | $311.3M | |
Gross Profit | $215.1M | $274.2M | $272.2M | $265.5M | $253.2M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $80.4M | $91.7M | $90.4M | $96.9M | $94M | |
Selling, General & Admin | $203M | $262.9M | $236.2M | $263.8M | $232.8M | |
Other Inc / (Exp) | -$386.2M | -- | $39.1M | -- | -- | |
Operating Expenses | $283.4M | $354.6M | $326.6M | $360.8M | $326.8M | |
Operating Income | -$68.3M | -$80.4M | -$54.4M | -$95.2M | -$73.6M | |
Net Interest Expenses | $123K | $3.1M | -- | -- | -- | |
EBT. Incl. Unusual Items | -$454.6M | -$69M | -$12.9M | -$91.8M | -$71.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$17.6M | -$3M | $9.3M | $2.7M | $2.7M | |
Net Income to Company | -$441.2M | -$64M | -$30.3M | -$126.8M | -$107.4M | |
Minority Interest in Earnings | $310K | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$440.9M | -$64M | -$30.3M | -$126.8M | -$107.4M | |
Basic EPS (Cont. Ops) | -$7.98 | -$0.98 | -$0.46 | -$1.83 | -$1.50 | |
Diluted EPS (Cont. Ops) | -$7.98 | -$0.98 | -$0.46 | -$1.83 | -$1.50 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$17.4M | -$22.8M | $1.8M | -$45.7M | -$29.8M | |
EBIT | -$68.3M | -$80.4M | -$54.4M | -$95.2M | -$73.6M | |
Revenue (Reported) | $522.1M | $636.5M | $637.4M | $622.3M | $564.5M | |
Operating Income (Reported) | -$68.3M | -$80.4M | -$54.4M | -$95.2M | -$73.6M | |
Operating Income (Adjusted) | -$68.3M | -$80.4M | -$54.4M | -$95.2M | -$73.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $134.2M | $163.4M | $149.4M | $144.1M | $136M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $78.6M | $93.8M | $84M | $80.2M | $75.8M | |
Gross Profit | $55.6M | $69.7M | $65.4M | $63.9M | $60.2M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $20.6M | $24M | $21.5M | $24M | $18.8M | |
Selling, General & Admin | $53.3M | $65.3M | $60.7M | $64.4M | $53.9M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $73.9M | $89.3M | $82.2M | $88.4M | $72.6M | |
Operating Income | -$18.4M | -$19.6M | -$16.8M | -$24.5M | -$12.4M | |
Net Interest Expenses | $377K | $1.4M | -- | -- | -- | |
EBT. Incl. Unusual Items | -$18.7M | -$20.9M | -$16M | -$23.2M | -$10.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$942K | -$73K | $3.8M | $716K | $455K | |
Net Income to Company | -$18.9M | -$20.9M | -$22.2M | -$26M | -$13.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$18.9M | -$20.9M | -$22.2M | -$26M | -$13.1M | |
Basic EPS (Cont. Ops) | -$0.32 | -$0.32 | -$0.33 | -$0.37 | -$0.18 | |
Diluted EPS (Cont. Ops) | -$0.32 | -$0.32 | -$0.33 | -$0.37 | -$0.18 | |
Weighted Average Basic Share | $58.6M | $65.7M | $67.6M | $70M | $72M | |
Weighted Average Diluted Share | $58.6M | $65.7M | $67.6M | $70M | $72M | |
EBITDA | -$4.6M | -$4.3M | -$5.1M | -$12.2M | -$1.6M | |
EBIT | -$18.4M | -$19.6M | -$16.8M | -$24.5M | -$12.4M | |
Revenue (Reported) | $134.2M | $163.4M | $149.4M | $144.1M | $136M | |
Operating Income (Reported) | -$18.4M | -$19.6M | -$16.8M | -$24.5M | -$12.4M | |
Operating Income (Adjusted) | -$18.4M | -$19.6M | -$16.8M | -$24.5M | -$12.4M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $272.1M | $243.2M | $150.5M | $82.6M | $70.2M | |
Short Term Investments | $27M | $259M | $177.4M | $80M | $80.5M | |
Accounts Receivable, Net | $106.1M | $129.4M | $144.7M | $172M | $153M | |
Inventory | $131.7M | $129.1M | $194.1M | $193M | $179.8M | |
Prepaid Expenses | $6.7M | $6.9M | $5.8M | $7.9M | $7.6M | |
Other Current Assets | $16.9M | $33.1M | $27.8M | $24.6M | $21.8M | |
Total Current Assets | $560.5M | $800.7M | $700.2M | $560.1M | $513M | |
Property Plant And Equipment | $222.5M | $217.9M | $213.2M | $216.4M | $216.5M | |
Long-Term Investments | $24.3M | $28.7M | $141.6M | $115.1M | $80.2M | |
Goodwill | $35.7M | $65.1M | $65M | $100.1M | $99.1M | |
Other Intangibles | $131.6M | $152.2M | $121.4M | $127.8M | $106.3M | |
Other Long-Term Assets | $15.5M | $12.5M | $18.4M | $14.4M | $14.7M | |
Total Assets | $990M | $1.3B | $1.3B | $1.1B | $1B | |
Accounts Payable | $17M | $52M | $72.9M | $46.8M | $45M | |
Accrued Expenses | $31.1M | $55.4M | $45.9M | $36.7M | $39.7M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $9.3M | $7.3M | $7.2M | $6.5M | $6.9M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $132.2M | $210.5M | $210.7M | $176.4M | $167.2M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $230.4M | $321.2M | $300.4M | $249.1M | $236.8M | |
Common Stock | $155K | $182K | $187K | $195K | $202K | |
Other Common Equity Adj | -$8.8M | -$8.8M | -$12.8M | -$7.1M | -$8M | |
Common Equity | $759.4M | $956M | $959.4M | $884.8M | $793M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $227K | -- | -- | -- | -- | |
Total Equity | $759.6M | $956M | $959.4M | $884.8M | $793M | |
Total Liabilities and Equity | $990M | $1.3B | $1.3B | $1.1B | $1B | |
Cash and Short Terms | $299.1M | $502.2M | $327.8M | $162.6M | $150.7M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $421.4M | $293.6M | $209.1M | $91.1M | $70.1M | |
Short Term Investments | $109M | $182M | $78.4M | $70M | $80M | |
Accounts Receivable, Net | $102.8M | $136.4M | $144.5M | $155.3M | $156.2M | |
Inventory | $124.2M | $143.1M | $202M | $195.1M | $169.9M | |
Prepaid Expenses | $10.3M | $8.5M | $8.5M | $9.5M | $10.6M | |
Other Current Assets | $16.7M | $24.2M | $22.5M | $21.1M | $20.9M | |
Total Current Assets | $784.5M | $787.9M | $665M | $542.1M | $507.6M | |
Property Plant And Equipment | $218.5M | $214.8M | $213.9M | $207.5M | $218M | |
Long-Term Investments | -- | $28.7M | $140.6M | $116.3M | $81.5M | |
Goodwill | $38.1M | $65.1M | $69.7M | $99.1M | $99.5M | |
Other Intangibles | $131.6M | $143.3M | $129.8M | $121.2M | $101.6M | |
Other Long-Term Assets | $43.3M | $16.7M | $18.1M | $13.8M | $15M | |
Total Assets | $1.2B | $1.3B | $1.2B | $1.1B | $1B | |
Accounts Payable | $28.1M | $59M | $54.8M | $37.8M | $38M | |
Accrued Expenses | $29.3M | $44.2M | $49.6M | $32.6M | $36.3M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $8.9M | $7.2M | $6.7M | $5.9M | $6.9M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $146.6M | $201M | $202.1M | $168.2M | $168.1M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $244.1M | $313.7M | $292.6M | $233.9M | $238.3M | |
Common Stock | $181K | $185K | $190K | $197K | $203K | |
Other Common Equity Adj | -$7.6M | -$9.8M | -$13.8M | -$8.6M | -$9.3M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $971.8M | $942.7M | $944.5M | $866.2M | $784.8M | |
Total Liabilities and Equity | $1.2B | $1.3B | $1.2B | $1.1B | $1B | |
Cash and Short Terms | $530.4M | $475.6M | $287.6M | $161.1M | $150.1M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$444.1M | -$62M | -$29M | -$123.1M | -$120.3M | |
Depreciation & Amoritzation | $49.6M | $56.1M | $59.8M | $49M | $45.3M | |
Stock-Based Compensation | $20.2M | $31M | $33.5M | $31.6M | $25.6M | |
Change in Accounts Receivable | $29.5M | -$25M | -$28.9M | -$25.7M | $4.5M | |
Change in Inventories | $37.1M | -$53K | -$87.3M | $4.6M | $9.4M | |
Cash From Operations | $27.8M | $35.8M | -$75.4M | -$61.6M | $7.8M | |
Capital Expenditures | $29M | $26.8M | $19.8M | $15M | $12.7M | |
Cash Acquisitions | -$24.9M | -$20.6M | -$69.1M | -$84.6M | -$1.7M | |
Cash From Investing | -$52.6M | -$291.2M | -$7.2M | -$3.8M | -$14.8M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -$2M | |
Other Financing Activities | -- | $406K | -$3M | -$1.5M | -$1.5M | |
Cash From Financing | $228K | $227.3M | -$2.8M | -$1.5M | -$3.3M | |
Beginning Cash (CF) | $293.6M | $272.2M | $243.3M | $150.7M | $82.9M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$24.6M | -$28M | -$85.4M | -$67M | -$10.3M | |
Ending Cash (CF) | $272.2M | $243.3M | $150.7M | $82.9M | $71.1M | |
Levered Free Cash Flow | -$1.2M | $9.1M | -$95.2M | -$76.7M | -$4.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$18.9M | -$20.9M | -$22.2M | -$26M | -$13.1M | |
Depreciation & Amoritzation | $13.8M | $15.3M | $11.7M | $12.3M | $10.8M | |
Stock-Based Compensation | $7.2M | $8.5M | $8.2M | $8.6M | $6.2M | |
Change in Accounts Receivable | $2.6M | -$8M | $1.1M | $15.5M | -$4.8M | |
Change in Inventories | $7M | -$14.8M | -$10.1M | $897K | $9.9M | |
Cash From Operations | $22.8M | -$16.1M | -$17.9M | $7.3M | $4.5M | |
Capital Expenditures | $4.3M | $4.2M | $4M | $3M | $4.2M | |
Cash Acquisitions | -$6.4M | -$5M | -$18.9M | -$5M | -$330K | |
Cash From Investing | -$92.7M | $67.7M | $75.9M | $1.9M | -$4.1M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | $407K | $866K | $851K | $35K | $200K | |
Cash From Financing | $222.2M | $1M | $855K | $184K | $200K | |
Beginning Cash (CF) | $272.2M | $243.3M | $150.7M | $82.9M | $71.1M | |
Foreign Exchange Rate Adjustment | -$2.9M | -$2.2M | -$168K | -$925K | -$841K | |
Additions / Reductions | $152.2M | $52.7M | $58.9M | $9.4M | $654K | |
Ending Cash (CF) | $421.5M | $293.8M | $209.4M | $91.4M | $70.9M | |
Levered Free Cash Flow | $18.5M | -$20.2M | -$22M | $4.4M | $304K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$441.2M | -$64M | -$30.3M | -$126.8M | -$107.4M | |
Depreciation & Amoritzation | $50.9M | $57.6M | $56.2M | $49.6M | $43.8M | |
Stock-Based Compensation | $22.5M | $32.3M | $33.2M | $32M | $23.2M | |
Change in Accounts Receivable | $15.5M | -$35.6M | -$19.8M | -$11.3M | -$15.8M | |
Change in Inventories | $49.8M | -$21.9M | -$82.7M | $15.6M | $18.4M | |
Cash From Operations | $39.3M | -$3M | -$77.3M | -$36.4M | $5M | |
Capital Expenditures | $26.6M | $26.6M | $19.6M | $14M | $14M | |
Cash Acquisitions | -$32.3M | -$19.2M | -$83.1M | -$70.6M | $3M | |
Cash From Investing | -$139.9M | -$130.7M | $971K | -$77.9M | -$20.8M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | $865K | -$3.1M | -$2.3M | -$1.3M | |
Cash From Financing | $222.4M | $6.2M | -$2.9M | -$2.2M | -$3.3M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $121.8M | -$127.5M | -$79.2M | -$116.4M | -$19.1M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $12.7M | -$29.6M | -$96.9M | -$50.4M | -$8.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$18.9M | -$20.9M | -$22.2M | -$26M | -$13.1M | |
Depreciation & Amoritzation | $13.8M | $15.3M | $11.7M | $12.3M | $10.8M | |
Stock-Based Compensation | $7.2M | $8.5M | $8.2M | $8.6M | $6.2M | |
Change in Accounts Receivable | $2.6M | -$8M | $1.1M | $15.5M | -$4.8M | |
Change in Inventories | $7M | -$14.8M | -$10.1M | $897K | $9.9M | |
Cash From Operations | $22.8M | -$16.1M | -$17.9M | $7.3M | $4.5M | |
Capital Expenditures | $4.3M | $4.2M | $4M | $3M | $4.2M | |
Cash Acquisitions | -$6.4M | -$5M | -$18.9M | -$5M | -$330K | |
Cash From Investing | -$92.7M | $67.7M | $75.9M | $1.9M | -$4.1M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | $407K | $866K | $851K | $35K | $200K | |
Cash From Financing | $222.2M | $1M | $855K | $184K | $200K | |
Beginning Cash (CF) | $272.2M | $243.3M | $150.7M | $82.9M | $71.1M | |
Foreign Exchange Rate Adjustment | -$2.9M | -$2.2M | -$168K | -$925K | -$841K | |
Additions / Reductions | $152.2M | $52.7M | $58.9M | $9.4M | $654K | |
Ending Cash (CF) | $421.5M | $293.8M | $209.4M | $91.4M | $70.9M | |
Levered Free Cash Flow | $18.5M | -$20.2M | -$22M | $4.4M | $304K |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.